Bernhard Ehmer

Dr. Bernhard Ehmer
Chairman of the Supervisory Board Heidelberg, Germany Shareholder representative Member since: May 2022
Personal Information
Date of Birth:	03 February 1955
Place of Birth:	Kandel, Germany
Nationality:	German
Education
Faculty of Medicine, Ruprecht-Karls-University of Heidelberg, 1976 - 1982
Career
2014 – 2019	Biotest AG, CEO
2008 - 2012	Imclone Group Imclone Systems Corporation, President Imclone Systems International GmbH, Managing Director and Senior VP
2007 - 2008	Fresenius Biotech, CEO
2006 - 2007	Biopheresis GmbH & Inc., CEO & Managing Director
1998 - 2006	Merck Group Merck KGaA, Head Corporate Strategic Planning & Alliance Management, Vice President Merck KGaA/EMD Pharmaceuticals Head Business Area Oncology, Vice President Merck KGaA Darmstadt, Head of Clinical R&D Operations
1986 - 1998	Boehringer Mannheim Boehringer Mannheim GmbH, Head Therapeutics (Regional Office Singapure), Head of Medical Operations Boehringer Mannheim Monza (Italy), Medical Project Leader Boehringer Mannheim GmbH, Medical Advisor & Medical Project Leader
1983 - 1986	Academic Teaching Hospital University of Heidelberg, Resident Internal Medicine
Membership in Supervisory Boards and Comparable Controlling Bodies
Affimed N.V. – Member of the Board

Locations